美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

三生製藥

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：- -

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

《大行報告》富瑞下調三生製藥(01530.HK)目標價至9元評級「持有」

阿斯达克财经

《半日速報》恒指升210點; 恒生科技指數升47點美團升逾3% 百威亞太、九毛九、中國中免、六福、三生製藥創新高

阿斯达克财经

三生製藥(01530)委任張丹為獨立非執行董事

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SSRX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SSRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSRX\",,,,,undefined,":{"symbol":"SSRX","market":"US","secType":"STK","nameCN":"三生製藥","latestPrice":0,"timestamp":0,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"盤前交易","change":0,"latestTime":"02-10 06:02:24 EST","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSRX\",,,,,undefined,":{"symbol":"SSRX","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSRX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSRX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2304574955","title":"《大行報告》富瑞下調三生製藥(01530.HK)目標價至9元  評級「持有」","url":"https://stock-news.laohu8.com/highlight/detail?id=2304574955","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304574955?lang=zh_tw&edition=fundamental","pubTime":"2023-01-18 09:54","pubTimestamp":1674006840,"startTime":"0","endTime":"0","summary":"富瑞发表研究报告指，三生制药的核心产品特比澳获中国工信部审核，用于治疗在儿童或青少年的慢性原发性免疫性血小板减少症，数据显示产品三期临床研究已达到预设有效率主要终点，见效快并具良好安全性。考虑到公司的产品管线、市场竞争、合作、监管等因素，富瑞将三生制药目标价由10元降至9元，评级“持有”。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20191009132908649_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20191009132908649_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1239807/latest-news/HK6","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1239807/latest-news/HK6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SSRX","01530"],"gpt_icon":0},{"id":"2301728928","title":"《半日速報》恒指升210點; 恒生科技指數升47點 美團升逾3% 百威亞太、九毛九、中國中免、六福、三生製藥創新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2301728928","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301728928?lang=zh_tw&edition=fundamental","pubTime":"2023-01-05 12:12","pubTimestamp":1672891920,"startTime":"0","endTime":"0","summary":"恒指半日收21,003点，升210点或1.0%。恒生科技指数报4,474点，升47点或1.1%。国指升84点或1.2%，报7,150点。沽空资料截至 2023-01-04 16:25。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190213170708072_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190213170708072_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1236800/latest-news/HK6","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1236800/latest-news/HK6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0072913022.USD","LU0577902298.EUR","513600","BK1233","LU1720050803.USD","BK1224","LU0543330483.HKD","LU0320764599.SGD","LU0878005551.USD","LU0348805143.USD","LU1794554557.SGD","LU0456846285.SGD","QNETCN","LU0417516738.SGD","LU0873338254.USD","LU1328615791.USD","LU0708995583.HKD","LU0456827905.SGD","BK1521","HHImain","LU0326950275.SGD","BK1142","MCHmain","90013","01880","LU1688375341.USD","LU0823040885.USD","LU0918141887.USD","09922","BK1593","LU0348735423.USD","LU1242518931.SGD","LU0577902371.SGD","LU0348814723.USD","BK1591","LU0052750758.USD","LU0359201612.USD","LU0128522157.USD","LU0051755006.USD","LU0320764755.SGD","BK1589","01530","LU0577902538.SGD","LU1807302812.USD","SSRX","LU0417516902.SGD","HSI","LU0431992006.USD","LU0348825331.USD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2295908023","title":"三生製藥(01530)委任張丹為獨立非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2295908023","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2295908023?lang=zh_tw&edition=fundamental","pubTime":"2022-12-30 20:12","pubTimestamp":1672402326,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，唐柯先生辞任公司非执行董事及薪酬委员会成员，自2022年12月30日起生效。此外，张丹博士已获委任为公司独立非执行董事及薪酬委员会成员，自2022年12月30日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/855494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","SSRX","01530","BK1583"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SSRX\",params:#limit:6,delay:false,,,undefined,":[]}}